AICURA medical GmbH

AICURA Medical is a leading company in the field of data and Artificial Intelligence (AI), dedicated to transforming healthcare and life sciences. Founded in 2018, AICURA has developed an innovative platform that accelerates clinical research and improves patient care.

AICURA offers a cutting-edge Data x AI platform designed to accelerate clinical research and unlock the full potential of data. The platform includes:

• Pre-trained AI Models: Ready to use to support various clinical use cases.
• Multimodal Data Integration: A powerful, graph-based data layer for seamless integration of data from various sources.
• Data Curation and Exploration: Scalable deployment of AI models on proprietary and publicly available data to de-risk and accelerate clinical development[2][3].

The main mission of AICURA is to improve patient outcomes by creating a secure, collaborative data and AI ecosystem. The company connects biotech firms, healthcare providers, medtech companies, clinical researchers, and Contract Research Organizations (CROs) to establish a comprehensive network for data, technology, and knowledge transfer in healthcare[3].

AICURA is engaged in several initiatives to sustainably improve healthcare:

• Partnerships and Research: AICURA collaborates with leading academic institutions and research groups, such as Prof. Matthias Schroeter from the Max Planck Institute for Cognitive and Brain Research, to advance the efficient and accurate diagnosis of neurodegenerative diseases[2].
• Promotion of AI Solutions: The company supports biopharma companies in evaluating data and imaging using AI to predict patient responses to drugs, identify ideal candidates for clinical trials, and accelerate drug development[1].
• Recognitions and Awards: AICURA has been selected as one of the Hello Tomorrow Deep Tech Pioneers and will participate in the Global Summit in Paris, highlighting its ability to develop innovative solutions in the healthcare sector[2].